Research & Discovery

Company researchers showed that the agents could selectively target single point mutations not associated with protein-binding pockets.

Avera Health will offer the TheraLink Assay to its employees and conduct studies to establish the clinical utility of the proteomic panel.

Interest in detection directly from specimens and antibiotic resistance is leading some researchers to look at methods likeREIMSand MRM-MS.

Advances in genetic technologies are paving the way to elucidate the pathophysiology of autism, according to an article in  Lancet Neurology.

DiaCarta will have the exclusive rights to develop a test for the early detection of colon cancer from stool samples and to commercialize it globally.